A clinical study to evaluate the role of shivagutika in pelvic inflammatory disease
Journal name: Journal of Ayurveda and Holistic Medicine
Original article title: A clinical study to evaluate the role of shivagutika in pelvic inflammatory disease
The Journal of Ayurveda and Holistic Medicine (JAHM) promotes Ayurvedic scientific research by offering a platform for in-depth exploration and integration of its principles into modern healthcare. JAHM is owned and published by Atreya Ayurveda Publications. Atreya Ayurveda Publications engaged in scientific publications on Ayurveda in the form of print books and ebooks since 2007.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
VISHWESH B.N.
Associate Professor, Department of Prasootitantra and Stri roga. SDM College of Ayurveda, Hassan, Karnataka-573201.
Journal of Ayurveda and Holistic Medicine:
Full text available for: A clinical study to evaluate the role of shivagutika in pelvic inflammatory disease
Year: 2014 | Doi: 10.70066/jahm.v2i1.145
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Background: Pelvic Inflammatory Disease is an infective condition of genital tract with symptoms like lower abdominal pain and tenderness, abnormal vaginal discharge, chills, and fever. Various yonivyapaths (Diseases of the female reproductive system), presenting the above said symptoms like adhodara shoola (Lower abdominal pain), shoola in maithuna (dyspareunia), jwara (fever) and yonisrava (discharge per vagina) include vatala (endometriosis), paripluta (pelvic inflammatory disease), mahayoni (genital organ prolapse) and so on. Aims and objectives: To evaluate the effect of an shivagutika in PID subjects with an intention to maximize its clinical effectiveness and hasten its integration into wider clinical practice. Materials and methods: Shivagutika was administered twice daily with honey after food intake for 60 days. The signs and symptoms of PID were graded before and during the course of treatment. In most of the cases, there was a progressive reduction in the symptoms with time, indicating the efficacy of the formulation in PID. Conclusion: Shiva gutika efficiently decreases the symptoms of PID, clinically controls infection and can be recommended in the management of Pelvic Inflammatory Disease.
Other Science Concepts:
Discover the significance of concepts within the article: ‘A clinical study to evaluate the role of shivagutika in pelvic inflammatory disease’. Further sources in the context of Science might help you critically compare this page with similair documents:
Shilajit, Dysmenorrhea, Follow-up, Main ingredient, Vaginal Discharge, Significant reduction, Age-group, Inclusion criteria, Exclusion criteria, Clinical Signs and Symptoms, Ethical committee, Study population, Pelvic Inflammatory Disease, Lower abdominal pain, Abnormal vaginal discharge, Shivagutika, Inclusion and exclusion criteria, Antimicrobial activities, Ethical committee approval, Follow up study, Chronic pelvic pain, Clinical effectiveness, Menstrual abnormalities, Dyspareunia, Pharmacological activity, Ultrasonography findings, Cost effective management, Nonsurgical management, Statistically significant reduction, Therapeutic goal.